Colorectal cancer: proportion of patients with colon cancer who undergo CT chest, abdomen and pelvis before definitive treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with cutaneous melanoma undergoing groin block dissection who have been referred to a lymphoedema service.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with unresectable stage III and IV cutaneous melanoma who undergo systemic anti-cancer therapy (SACT).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with stage III and IV cutaneous melanoma who undergo CT or positron emission tomography (PET) CT prior to completion lymphadenectomy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with unresectable stage III or IV cutaneous melanoma who have their BRAF status checked.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with cutaneous melanoma undergoing wide local excision within 84 days of their partial biopsy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with cutaneous melanoma undergoing wide local excision within 84 days of their diagnostic excision biopsy.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with cutaneous melanoma undergoing partial biopsy who undergo a wide local excision.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with cutaneous melanoma undergoing diagnostic excision biopsy who undergo a wide local excision.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with cutaneous melanoma who undergo sentinel node biopsy (SNB) where the SNB report contains a full set of data items (as defined by the current Royal College of Pathologists dataset).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with cutaneous melanoma undergoing clinical examination of relevant draining lymph node basins as part of clinical staging.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with cutaneous melanoma who are discussed at a multidisciplinary team (MDT) meeting before definitive treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with cutaneous melanoma who undergo diagnostic excision biopsy where the surgical pathology report contains a full set of data items (as defined by the current Royal College of Pathologists dataset).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Cutaneous melanoma: proportion of patients with cutaneous melanoma who have their diagnostic excision biopsy carried out by a skin cancer clinician.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Lung cancer: proportion of patients with lung cancer who are enrolled in an interventional clinical trial or translational research.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Lung cancer: proportion of patients with N2 disease who receive curative treatment (radical radiotherapy, radical chemoradiotherapy or surgical resection) who undergo contrast enhanced CT or contrast enhanced MRI prior to start of treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Lung cancer: proportion of patients with lung cancer who receive curative treatment (radical radiotherapy, radical chemoradiotherapy or surgical resection) who have a cytological/histological diagnosis prior to treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Lung cancer: proportion of patients with stage I lung cancer not undergoing surgery who receive stereotactic ablative radiotherapy (SABR).
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Lung cancer: proportion of patients with lung cancer who receive treatment with curative intent (surgery, radical radiotherapy or chemoradiotherapy) who die within 90 days of treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service
Lung cancer: proportion of patients with lung cancer who receive active treatment who die within 30 days of treatment.
- Published By NHS Scotland, Scottish Cancer Taskforce
- Measurement Settings Ambulatory/Office-based Care, Ambulatory Procedure/Imaging Center, Hospital Inpatient, Hospital Outpatient
- Professionals Involved In the Delivery of Service